52536-180 : Erythromycin 250 mg Oral Tablet, Delayed Release

NDC:	52536-180
Labeler:	Wilshire Pharmaceuticals
Product Type:	Human Prescription Drug
Drug Name:	Erythromycin
Dosage Form:	Oral Tablet, Delayed Release
Application #:	ANDA062298
Rev. Date:	Jul 22, 2019

Appearance:

Markings:	EC
Shapes:	Oval
Colors:	White
Size (mm):	15
Segments: *	1
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

• 52536-180-03: 30 TABLET, DELAYED RELEASE IN 1 BOTTLE (52536‑180‑03)
• 52536-180-10: 100 TABLET, DELAYED RELEASE IN 1 BOTTLE (52536‑180‑10)

Active Ingredients:

• Erythromycin

Inactive Ingredients:

• Silicon Dioxide
• Croscarmellose Sodium
• Crospovidone (15 Mpa.s At 5%)
• Diacetylated Monoglycerides
• Hydroxypropyl Cellulose (1600000 Wamw)
• Hypromellose, Unspecified
• Hypromellose Phthalate (24% Phthalate, 55 Cst)
• Magnesium Stearate
• Microcrystalline Cellulose
• Povidone, Unspecified
• Propylene Glycol
• Sodium Citrate, Unspecified Form
• Sorbitan Monooleate
• Talc
• Titanium Dioxide /

Pharmaceutical Classes:

• Decreased Sebaceous Gland Activity [PE]
• Macrolide Antimicrobial [EPC]
• Macrolide [EPC]
• Macrolides [CS]

Related Products:

• 52536-103 Erythromycin 250 mg Oral Tablet, Film Coated by Wilshire Pharmaceuticals
• 52536-105 Erythromycin 500 mg Oral Tablet, Film Coated by Wilshire Pharmaceuticals
• 52536-183 Erythromycin 333 mg Oral Tablet, Delayed Release by Wilshire Pharmaceuticals
• 52536-186 Erythromycin 500 mg Oral Tablet, Delayed Release by Wilshire Pharmaceuticals
• 0051-3389 Erythromycin 500 mg Oral Tablet by Abbvie Inc.
• 0051-6227 Erythromycin 500 mg Oral Tablet, Film Coated by Abbvie Inc.
• 0051-6290 Erythromycin 333 mg Oral Tablet by Abbvie Inc.
• 0051-6301 Erythromycin 250 mg Oral Capsule, Delayed Release by Abbvie Inc.
• 0051-6320 Erythromycin 333 mg Oral Tablet, Delayed Release by Abbvie Inc.
• 0051-6321 Erythromycin 500 mg Oral Tablet, Delayed Release by Abbvie Inc.
• 0051-6326 Erythromycin 250 mg Oral Tablet, Film Coated by Abbvie Inc.
• 0093-5571 Erythromycin 250 mg Oral Tablet, Film Coated by Teva Pharmaceuticals USA, Inc.
• 0093-5572 Erythromycin 500 mg Oral Tablet, Film Coated by Teva Pharmaceuticals USA, Inc.
• 0168-0215 Erythromycin 20 mg/ml Topical Solution by E. Fougera & Co., a Division of Fougera Pharmaceuticals Inc.
• 0168-0216 Erythromycin 20 mg/g Topical Gel by E. Fougera & Co., a Division of Fougera Pharmaceuticals Inc.
• 0179-0117 Erythromycin 250 mg Delayed Release Capsule by Kaiser Foundation Hospitals
• 0378-8212 Erythromycin 20 mg/g Topical Gel by Mylan Pharmaceuticals Inc.
• 0404-7191 Erythromycin 5 mg/g Ophthalmic Ointment by Henry Schein Inc.
• 0574-4024 Erythromycin 5 mg/g Ophthalmic Ointment by Paddock Laboratories, LLC
• 13668-586 Erythromycin 250 mg Oral Tablet, Delayed Release by Torrent Pharmaceuticals Limited
• More related products ...

NDC QR Code

Related Discussions: